1. Home
  2. OLMA vs IPI Comparison

OLMA vs IPI Comparison

Compare OLMA & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • IPI
  • Stock Information
  • Founded
  • OLMA 2006
  • IPI 2000
  • Country
  • OLMA United States
  • IPI United States
  • Employees
  • OLMA N/A
  • IPI N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • OLMA Health Care
  • IPI Industrials
  • Exchange
  • OLMA Nasdaq
  • IPI Nasdaq
  • Market Cap
  • OLMA 289.0M
  • IPI 336.4M
  • IPO Year
  • OLMA 2020
  • IPI 2008
  • Fundamental
  • Price
  • OLMA $4.42
  • IPI $29.08
  • Analyst Decision
  • OLMA Strong Buy
  • IPI Sell
  • Analyst Count
  • OLMA 3
  • IPI 2
  • Target Price
  • OLMA $27.67
  • IPI $21.00
  • AVG Volume (30 Days)
  • OLMA 1.2M
  • IPI 212.3K
  • Earning Date
  • OLMA 05-07-2025
  • IPI 05-07-2025
  • Dividend Yield
  • OLMA N/A
  • IPI N/A
  • EPS Growth
  • OLMA N/A
  • IPI N/A
  • EPS
  • OLMA N/A
  • IPI N/A
  • Revenue
  • OLMA N/A
  • IPI $204,454,000.00
  • Revenue This Year
  • OLMA N/A
  • IPI $9.48
  • Revenue Next Year
  • OLMA N/A
  • IPI $3.13
  • P/E Ratio
  • OLMA N/A
  • IPI N/A
  • Revenue Growth
  • OLMA N/A
  • IPI N/A
  • 52 Week Low
  • OLMA $2.86
  • IPI $18.83
  • 52 Week High
  • OLMA $16.62
  • IPI $31.29
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 60.78
  • IPI 55.95
  • Support Level
  • OLMA $2.96
  • IPI $28.42
  • Resistance Level
  • OLMA $3.41
  • IPI $30.10
  • Average True Range (ATR)
  • OLMA 0.35
  • IPI 1.89
  • MACD
  • OLMA 0.16
  • IPI 0.09
  • Stochastic Oscillator
  • OLMA 98.73
  • IPI 82.53

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About IPI Intrepid Potash Inc

Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.

Share on Social Networks: